Objectives

After participating in this educational activity, attendees should be able to:
1. Recognize the mechanism of action of biologic therapies available for childhood atopic dermatitis.
2. Identify the side effects of biologic therapies available for childhood atopic dermatitis.
3. Restate the efficacy of the biologic therapies for childhood atopic dermatitis.

Faculty

Richard J. Antaya, MD
Professor of Dermatology, Pediatrics & Nursing
Yale University

 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

The speaker attests that he is currently receiving grant/research support from Leo Pharma for a clinical trial and had received royalty from an advisory board.

                                                                             

Session date: 
Tuesday, March 23, 2021 - 8:00am to 9:00am
Location: 
Webinar Live
MA
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.